Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangdong Su

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|November 3, 2025
Basal mantle structure regenerated through supercontinentsPeng Peng, Ross N Mitchell, Nan Zhang, et al.
Chemmedchem|June 30, 2011
Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1Xiangdong Su, Fabienne Pradaux-Caggiano, Nigel Vicker, et al.
ACS Omega|November 16, 2020
Inositol Adenophostin: Convergent Synthesis of a Potent Agonist of d-<i>myo</i>-Inositol 1,4,5-Trisphosphate ReceptorsXiangdong Su, Wolfgang Dohle, Stephen J Mills, et al.
Materials (Basel, Switzerland)|October 13, 2021
Continuous, Large-Scale, and High Proportion of Bioinspired Phosphogypsum Composites via Reactive ExtrusionJingyu Ran, Xiangdong Su, Jiangang Zhang, et al.
Molecules (Basel, Switzerland)|November 27, 2021
Regioisomers Salviprolin A and B, Unprecedented Rosmarinic Acid Conjugated Dinorditerpenoids from <i>Salvia przewalskii</i> MaximXiangdong Su, Yichuang Wu, Meifang Wu, et al.
Chemmedchem|May 21, 2010
Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitorsXiangdong Su, Fabienne Pradaux-Caggiano, Mark P Thomas, et al.
Journal of Pharmaceutical Analysis|October 6, 2025
Discovery of selective HDAC6 inhibitors driven by artificial intelligence and molecular dynamics simulation approachesXingang Liu, Hao Yang, Xinyu Liu, et al.
European Journal of Medicinal Chemistry|May 18, 2025
Targeted degradation of DDR1 by proteolytic targeting chimera reverses immune exclusion for tumor immunotherapyXiaoyu Wang, Jiangmeng Zeng, Shilin Liu, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|November 3, 2025
Basal mantle structure regenerated through supercontinentsPeng Peng, Ross N Mitchell, Nan Zhang, et al.
Chemmedchem|June 30, 2011
Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1Xiangdong Su, Fabienne Pradaux-Caggiano, Nigel Vicker, et al.
ACS Omega|November 16, 2020
Inositol Adenophostin: Convergent Synthesis of a Potent Agonist of d-<i>myo</i>-Inositol 1,4,5-Trisphosphate ReceptorsXiangdong Su, Wolfgang Dohle, Stephen J Mills, et al.
Materials (Basel, Switzerland)|October 13, 2021
Continuous, Large-Scale, and High Proportion of Bioinspired Phosphogypsum Composites via Reactive ExtrusionJingyu Ran, Xiangdong Su, Jiangang Zhang, et al.
Molecules (Basel, Switzerland)|November 27, 2021
Regioisomers Salviprolin A and B, Unprecedented Rosmarinic Acid Conjugated Dinorditerpenoids from <i>Salvia przewalskii</i> MaximXiangdong Su, Yichuang Wu, Meifang Wu, et al.
Chemmedchem|May 21, 2010
Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitorsXiangdong Su, Fabienne Pradaux-Caggiano, Mark P Thomas, et al.
Journal of Pharmaceutical Analysis|October 6, 2025
Discovery of selective HDAC6 inhibitors driven by artificial intelligence and molecular dynamics simulation approachesXingang Liu, Hao Yang, Xinyu Liu, et al.
European Journal of Medicinal Chemistry|May 18, 2025
Targeted degradation of DDR1 by proteolytic targeting chimera reverses immune exclusion for tumor immunotherapyXiaoyu Wang, Jiangmeng Zeng, Shilin Liu, et al.
Pageof 4